What type of drug classification does Guanfacine belong to?

Guanfacine is a selectiveα2A-adrenergic receptor agonist. It was originally developed to treat hypertension because it can reduce peripheral vascular tone and reduce the burden on the heart. However, with the deepening of research, it was discovered that it plays an important role in the regulation of the prefrontal cortex in the central nervous system, especially in regulating attention, controlling impulses and enhancing working memory. Therefore, guanfacine is also classified as a neuropsychiatric drug, especially one of the non-stimulant drugs used to treat attention deficit hyperactivity disorder (ADHD).

In terms of pharmacological mechanism, guanfacine activates α2A receptors in the central nervous system and reduces the release of the neurotransmitter norepinephrine, thereby sedating, reducing impulsivity and improving behavioral control. Unlike traditional central stimulants such as methylphenidate and amphetamines, guanfacine does not directly stimulate the cerebral cortex, but achieves therapeutic effects by stabilizing neural circuits. Therefore, guanfacine is considered an important alternative for some ADHD patients who cannot tolerate stimulating drugs or have comorbidities such as anxiety and sleep disorders.

In addition, guanfacine has also been studied to treat a range of neurobehavioral-related diseases, such as Tourette syndrome, generalized anxiety disorder, and emotion regulation problems in autism spectrum disorder. Especially in children and adolescents, due to its low risk of addiction and its effect on improving sleep quality, it has gradually become a candidate for combined medication or single-drug replacement treatment for ADHD in recent years.

Therefore, from the perspective of drug classification, guanfacine is both an antihypertensive drug and a central nervous system modulating drug. It is a representative non-stimulant drug in the treatment of neurodevelopmental diseases. It has multiple clinical adaptation potentials and is especially suitable for ADHD patients under certain special pathological conditions.